ENDRA Life Sciences (NDRA) Other financing activities (2020 - 2024)

ENDRA Life Sciences (NDRA) has reported Other financing activities for 4 consecutive years, with -$4.0 million the latest figure, recorded in Q4 2024.

• On a quarterly basis, Other financing activities fell 498.85% year-over-year to -$4.0 million in Q4 2024; TTM through Jun 2025 was -$5.4 million, a 169.68% decrease from a year earlier, with the FY2024 full-year figure at $1.3 million, up 27.6% from the prior year.
• Other financing activities was -$4.0 million for Q4 2024 at ENDRA Life Sciences, down from -$1.3 million in the prior quarter.
• Over five years, Other financing activities peaked at $6.6 million in Q2 2024 and troughed at -$4.0 million in Q4 2024.
• A 4-year average of $899828.8 and a median of $77419.0 in 2024 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 32861.8% in 2024, down 498.85% in 2024.
• Over 4 years, Other financing activities stood at $112927.0 in 2020, then surged by 2366.75% to $2.8 million in 2021, then tumbled by 63.57% to $1.0 million in 2023, then plunged by 498.85% to -$4.0 million in 2024.
• The last three Other financing activities figures came in at -$4.0 million (Q4 2024), -$1.3 million (Q3 2024), and $6.6 million (Q2 2024), per Business Quant data.